• Latest

Early symptoms of Alzheimer’s disease

Dr Neeraj Balaini, Consultant -Neurology, Aster RV Hospital Memory loss is the most common symptom of Alzheimer's disease. However, sometimes…

• Health Care

Alzheimer’s care during covid-19 outbreak

By Dr. M. Jayasree,  Consultant Neurologist  KIMS Hospitals, Sec-bad. World Alzheimer’s Day on 21st September 2020 Alzheimer's disease (AD) is a…

• Hospitals

Understanding the link between hearing loss and dementia

National, September 17, 2020: Hearing loss has been shown to be linked to dementia in epidemiological studies and may be…

• Health Care

Eisai: Initiation of New Phase III Clinical Study (Ahead 3-45) of ban2401 Preclinical (Asymptomatic) Alzheimer’s Disease

New Delhi, July 14, 2020: The Alzheimer's Clinical Trials Consortium (ACTC), Eisai Co., Ltd., and Biogen Inc. announced today that…

• Latest

Biogen and Eisai to Discontinue Phase 3 ENGAGE and EMERGE Trials of aducanumab in Alzheimer’s Disease

Independent data monitoring committee advises aducanumab unlikely to meet primary endpoints, leading to decision to discontinue the trials Cambridge, March…

Biogen and Eisai Report Data from Long-Term Extension Phase 1b Study of Investigational Alzheimer’s Disease Treatment Aducanumab

Data Includes Additional Analyses of Long-Term Extension Phase 1b Study With Titration Cohort at 36 Months and Fixed-Dose Cohorts at…

Suven Life Sciences secures Product Patents in China and Sri Lanka

New Delhi, January 20, 2018: Suven Life SciencesBSE -0.92 % has secured a product patent each from China and Sri Lankacorresponding to the new chemical…